JAPAN LIFELINE CO.

JAPAN LIFELINE CO. Share · JP3754500001 · 912480 (XJPX) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of JAPAN LIFELINE CO.
No Price
01.05.2026 05:41
Current Prices from JAPAN LIFELINE CO.
ExchangeTickerCurrencyLast TradePriceDaily Change
XTKS: Tokyo
Tokyo
7575.T
JPY
01.05.2026 05:41
1.405,00 JPY
1,00 JPY
+0,07 %
Share Float & Liquidity
Free Float 67,38 %
Shares Float 47,27 M
Shares Outstanding 70,16 M
Invested Funds

The following funds have invested in JAPAN LIFELINE CO.:

Fund
iShares Core MSCI Japan IMI UCITS ETF USD (Dist)
Vol. in million
29,28
Percentage (%)
0,02 %
Fund
iShares Core MSCI Japan IMI UCITS ETF EUR Hedged (Acc)
Vol. in million
11,96
Percentage (%)
0,02 %
Company Profile for JAPAN LIFELINE CO. Share
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts; and transvascular intervention products include PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and atrial septal defect closure devices. The company offers gastrointestinal intervention products that consist of radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.

Company Data

Name JAPAN LIFELINE CO.
Company Japan Lifeline Co., Ltd.
Website https://www.japanlifeline.com
Primary Exchange XJPX Frankfurt
WKN 912480
ISIN JP3754500001
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Keisuke Suzuki
Market Capitalization 99 Mrd.
Country Japan
Currency EUR
Employees 1,2 T
Address Tennoz Ocean Square, 140-0002 Tokyo
IPO Date 2000-01-04
Dividends from 'JAPAN LIFELINE CO.'
Ex-Date Dividend per Share
30.03.2026 43,03 JPY
28.03.2025 53,00 JPY
28.03.2024 42,00 JPY
30.03.2023 38,00 JPY
30.03.2022 38,00 JPY
30.03.2021 20,00 JPY
30.03.2020 29,00 JPY
27.03.2019 29,00 JPY
28.03.2018 28,75 JPY
29.03.2017 30,00 JPY

Stock Splits

Date Split
27.12.2017 2:1
28.11.2016 2:1
28.09.2015 2:1

Ticker Symbols

Name Symbol
Frankfurt L8B.F
Tokyo 7575.T
More Shares
Investors who hold JAPAN LIFELINE CO. also have the following shares in their portfolio:
AMUNDI S.F. - EURO CURVE 10+YEAR - H EUR (C)
AMUNDI S.F. - EURO CURVE 10+YEAR - H EUR (C) ETF
VALARIS LTD WTS28
VALARIS LTD WTS28 Share